SCHEMBL17952274

SCHEMBL17952274

Cc1cc(-c2ccccc2)ccc1N1c2c(C#N)ccc(C#N)c2N(C)[C@@H]1C

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ CYP11B1 P15538 1/20 0.35
▸ CYP11B2 P19099 1/20 0.35
▸ FABP5 Q01469 2/20 0.34
▸ FABP7 O15540 1/20 0.34
▸ FABP3 P05413 1/20 0.34
▸ GRIA2 P42262 1/20 0.33
▸ GRIA4 P48058 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ MAOB P27338 1/20 0.33
▸ AR P10275 5/20 0.33
▸ EGLN1 Q9GZT9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17952267 0.90 ALDH1A1 (0.36) ALDH1A1KDM4EGLAGAACYP11B1
SCHEMBL17952196 0.88 SMN1; SMN2 (0.36) ALDH1A1KDM4EGLAGAACYP11B1
SCHEMBL17947663 0.88 SMN1; SMN2 (0.36) ALDH1A1KDM4EGLAGAACYP11B1
SCHEMBL17952492 0.87 SMN1; SMN2 (0.36) ALDH1A1KDM4EGLAGAACYP11B1
SCHEMBL17952347 0.87 SMN1; SMN2 (0.36) ALDH1A1KDM4EGLAGAACYP11B1
SCHEMBL17952318 0.84 ALDH1A1 (0.37) ALDH1A1KDM4EGLAGAACYP11B1
SCHEMBL17952339 0.84 KDM4E (0.34) ALDH1A1KDM4EGLAGAACYP11B1
SCHEMBL17952325 0.84 KDM4E (0.34) ALDH1A1KDM4EGLAGAACYP11B1
SCHEMBL17952390 0.83 NPSR1 (0.36) ALDH1A1KDM4EHPGDMAOAMAOB
SCHEMBL17952388 0.83 TSHR (0.41) ALDH1A1KDM4EGLAGAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10418569-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2019-09-17 — — US disclosed
US-20160218303-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-07-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10418569-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, OSBP2 ALDH1A1 1620/4885KDM4E 4426/4885GLA 1850/4885
US-20160218303-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OSBP2 ALDH1A1 1620/4885KDM4E 4426/4885GLA 1850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback